These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29269290)
1. Pancreatic inflammation and atrophy are not associated with pancreatic cancer concomitant with intraductal papillary mucinous neoplasm. Yagi Y; Masuda A; Zen Y; Shiomi H; Toyama H; Sofue K; Takenaka M; Kobayashi T; Nakagawa T; Yamanaka K; Ikegawa T; Hoshi N; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T Pancreatology; 2018 Jan; 18(1):54-60. PubMed ID: 29269290 [TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm". Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246 [TBL] [Abstract][Full Text] [Related]
3. Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm. Kamata K; Takenaka M; Nakai A; Omoto S; Miyata T; Minaga K; Matsuda T; Yamao K; Imai H; Chiba Y; Sakurai T; Watanabe T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kudo M Oncology; 2017; 93 Suppl 1():102-106. PubMed ID: 29258117 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN). McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698 [TBL] [Abstract][Full Text] [Related]
5. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm. Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920 [TBL] [Abstract][Full Text] [Related]
7. Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm. Nakagawa T; Masuda A; Toyama H; Shiomi H; Zen Y; Sofue K; Takenaka M; Kobayashi T; Yagi Y; Yamanaka K; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T Pancreas; 2017 Apr; 46(4):582-588. PubMed ID: 28099253 [TBL] [Abstract][Full Text] [Related]
8. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310 [TBL] [Abstract][Full Text] [Related]
9. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma. Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092 [TBL] [Abstract][Full Text] [Related]
11. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis. Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212 [TBL] [Abstract][Full Text] [Related]
13. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Pea A; Yu J; Rezaee N; Luchini C; He J; Dal Molin M; Griffin JF; Fedor H; Fesharakizadeh S; Salvia R; Weiss MJ; Bassi C; Cameron JL; Zheng L; Scarpa A; Hruban RH; Lennon AM; Goggins M; Wolfgang CL; Wood LD Ann Surg; 2017 Jul; 266(1):133-141. PubMed ID: 27433916 [TBL] [Abstract][Full Text] [Related]
14. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study. Holmberg M; Radkiewicz C; Strömberg C; Öman M; Ghorbani P; Löhr JM; Sparrelid E Pancreatology; 2023 Jan; 23(1):90-97. PubMed ID: 36522260 [TBL] [Abstract][Full Text] [Related]
15. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas. Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608 [TBL] [Abstract][Full Text] [Related]
16. Imaging morphological changes of intraductal papillary mucinous neoplasm of the pancreas was associated with its malignant transformation but not with development of pancreatic ductal adenocarcinoma. Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y Pancreatology; 2015; 15(6):654-60. PubMed ID: 26433405 [TBL] [Abstract][Full Text] [Related]
17. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of low serum pancreatic enzymes in invasive intraductal papillary mucinous neoplasms. Yagi Y; Masuda A; Zen Y; Takenaka M; Toyama H; Sofue K; Shiomi H; Kobayashi T; Nakagawa T; Yamanaka K; Hoshi N; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T Pancreatology; 2016; 16(5):893-9. PubMed ID: 27394653 [TBL] [Abstract][Full Text] [Related]
19. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms. Yamada S; Fujii T; Hirakawa A; Takami H; Suenaga M; Hayashi M; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y Pancreas; 2018 Sep; 47(8):974-979. PubMed ID: 30028445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]